Mechanism Helping Brain Cancer Cells Multiply Discovered
Chloride ion flows play a crucial role in the duplication of glioblastoma cells, presenting new therapeutic targets.
Complete the form below to unlock access to ALL audio articles.
Chloride ion flows that enter the cells play an important role in the duplication of glioblastoma cells, a highly aggressive brain tumor. This is the finding of research recently published in the journal Molecular Cancer Research, led by research teams from SISSA (Scuola Internazionale Superiore di Studi Avanzati) in collaboration with IOM-CNR, the University of Trieste, University Hospital of Udine, the University of Udine and GlioGuard S.r.l.. The study revealed that socalled “Calcium-dependent chloride ion channels”, which act like “gates” regulating chloride ion flows in and out of the cell, play a role in regulating tumor cell lines division and thus their proliferation. By using substances that block these flows, the research group demonstrated that it is possible to stop replication in tumor cells cultured in the laboratory. This result points to ion currents as a potential target for future therapeutic approaches.
A higher concentration of chloride ions in cells promotes tumor progression
“Glioblastoma is the most common and malignant tumor among neoplasms of the non-neuronal cellular component of the central and peripheral nervous system, generally called ‘glia’. In glioblastoma cells, an increased concentration of chloride is found compared to normal levels” Anna Menini, one of the leaders of the study, explains: “For this reason we asked ourselves: can this increase aid tumor progression, and if so, how?”. To answer this question, the scientists used various experimental techniques on cells which resemble those in tumors, such as imaging of calcium and chloride channels, electrophysiology and immunocytochemistry. By doing so, the researchers demonstrated that chloride ion channels indeed have a direct influence on the replication of these cells. In particular, by allowing the influx of chloride ions into the cell they seem to help increase the cell's volume, a fundamental process that promotes division into two daughter cells.
Want more breaking news?
Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.
Subscribe for FREE
Ion flows to drive cell division
More specifically, Vincent Torre, another leader of the study, explains. “In glioblastoma cells undergoing division, we noticed three different phases. Initially, there is an increase in calcium concentration inside the cell. This process triggers the second phase: this calcium increase activates the chloride channels, allowing the entry of chloride ions. Finally, to maintain osmotic balance, glioblastoma cells swell until they divide into two daughter cells. This evidence,” the researchers explain, “indicates that these channels play a significant role in making the tumor cell grow so that it can divide and multiply, thereby promoting tumor progression.”
Blocking the chloride channels
To demonstrate this, the authors used specific substances that selectively block chloride channels, such as niflumic acid and carbenoxolone. Vincent Torre explains: “In laboratory experiments conducted using tumor cell lines, we observed that, when treated with these substances, the cells stop in the early stages of division, remaining in a rounded configuration and cease dividing and multiplying. These same channels could therefore be considered potential targets for novel drugs specifically designed to halt tumor progression. Given the high heterogeneity of glioblastoma cells, further in-depth studies will be needed before verifying the robustness of this hypothesis in patients, but a new route is open. The Editor of indeed notes this work could offer new possible approaches for GBM treatment”.
Reference: Li Y, Sanchez Triviño CA, Hernandez A, et al. Mechanisms of Glioblastoma Replication: Ca2+ Flares and Cl− Currents. Molecular Cancer Research. 2024;22(9):852-863. doi: 10.1158/1541-7786.MCR-23-0934
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.